Selected article for: "epithelial cell and recombinant virus"
Author: Haverkamp, Ann-Kathrin; Lehmbecker, Annika; Spitzbarth, Ingo; Widagdo, Widagdo; Haagmans, Bart L.; Segalés, Joaquim; Vergara-Alert, Julia; Bensaid, Albert; van den Brand, Judith M. A.; Osterhaus, Albert D. M. E.; Baumgärtner, Wolfgang
Title: Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4
  • Cord-id: kxivgxbg
  • Document date: 2018_6_27
    • ID: kxivgxbg
    Snippet: Middle East respiratory syndrome (MERS) represents an important respiratory disease accompanied by lethal outcome in one-third of human patients. Recent data indicate that dromedaries represent an important source of infection, although information regarding viral cell tropism and pathogenesis is sparse. In the current study, tissues of eight dromedaries receiving inoculation of MERS-Coronavirus (MERS-CoV) after recombinant Modified-Vaccinia-Virus-Ankara (MVA-S)-vaccination (n = 4), MVA-vaccinat
    Document: Middle East respiratory syndrome (MERS) represents an important respiratory disease accompanied by lethal outcome in one-third of human patients. Recent data indicate that dromedaries represent an important source of infection, although information regarding viral cell tropism and pathogenesis is sparse. In the current study, tissues of eight dromedaries receiving inoculation of MERS-Coronavirus (MERS-CoV) after recombinant Modified-Vaccinia-Virus-Ankara (MVA-S)-vaccination (n = 4), MVA-vaccination (mock vaccination, n = 2) and PBS application (mock vaccination, n = 2), respectively, were investigated. Tissues were analyzed by histology, immunohistochemistry, immunofluorescence, and scanning electron microscopy. MERS-CoV infection in mock-vaccinated dromedaries revealed high numbers of MERS-CoV-nucleocapsid positive cells, T cells, and macrophages within nasal turbinates and trachea at day four post infection. Double immunolabeling demonstrated cytokeratin (CK) 18 expressing epithelial cells to be the prevailing target cell of MERS-CoV, while CK5/6 and CK14 expressing cells did not co-localize with virus. In addition, virus was occasionally detected in macrophages. The acute disease was further accompanied by ciliary loss along with a lack of dipeptidyl peptidase 4 (DPP4), known to mediate virus entry. DPP4 was mainly expressed by human lymphocytes and dromedary monocytes, but overall the expression level was lower in dromedaries. The present study underlines significant species-specific manifestations of MERS and highlights ciliary loss as an important finding in dromedaries. The obtained results promote a better understanding of coronavirus infections, which pose major health challenges.

    Search related documents:
    Co phrase search for related documents
    • acute kidney injury and low respiratory: 1, 2, 3, 4
    • acute kidney injury and lung respiratory organ: 1
    • acute kidney injury and lung tumor: 1, 2
    • acute kidney injury and lymph node: 1, 2
    • acute pneumonia and adjacent cell: 1
    • acute pneumonia and low number: 1, 2
    • acute pneumonia and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8
    • acute pneumonia and lung respiratory organ: 1, 2, 3, 4
    • acute pneumonia and lung tumor: 1, 2
    • acute pneumonia and lymph node: 1, 2
    • acute pneumonia and lymphoid cell: 1
    • acute pneumonia and lymphoid peripheral blood: 1
    • acute pneumonia and macrophage lymphocyte: 1, 2
    • acute sars cov respiratory syndrome coronavirus and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • acute sars cov respiratory syndrome coronavirus and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • acute sars cov respiratory syndrome coronavirus and low respiratory tract: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and macrophage lymphocyte: 1
    • acute sars cov respiratory syndrome coronavirus and macrophage specific: 1, 2